About 4B Technologies
4B Technologies is a company based in Suzhou (China) founded in 2018 by Liu Jie. 4B Technologies has raised $14 million across 2 funding rounds from investors including Fortune Capital, Bloomage and Fangyi Equity Investment Fund. 4B Technologies operates in a competitive market with competitors including Biogen, Denali Therapeutics, Annexon, Entrada Therapeutics and Adamas Pharma, among others.
- Headquarter Suzhou, China
- Founders Liu Jie
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14 M (USD)
in 2 rounds
-
Latest Funding Round
$14 M (USD), Series A
Dec 12, 2022
-
Investors
Fortune Capital
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of 4B Technologies
4B Technologies has successfully raised a total of $14M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $14 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in 4B Technologies
4B Technologies has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Fortune Capital, Bloomage and Fangyi Equity Investment Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for 4B Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by 4B Technologies
Investment portfolio details for 4B Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - 4B Technologies
Detailed financials for 4B Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
4B Technologies Comparisons
Peer comparison for 4B Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of 4B Technologies
4B Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, Denali Therapeutics, Annexon, Entrada Therapeutics and Adamas Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| Locked | Locked | Locked |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| Locked | Locked | Locked |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| Locked | Locked | Locked |
Biologics platform developed for intracellular delivery in rare diseases.
|
|
| Locked | Locked | Locked |
Pharmacokinetic profiles of approved drugs are enhanced for CNS therapeutics.
|
|
| Locked | Locked | Locked |
T-cell-based therapies for autoimmune and degenerative diseases are developed.
|
Detailed competitors of 4B Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on 4B Technologies
Complete news archive for 4B Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about 4B Technologies
4B Technologies was founded in 2018 and raised its 1st funding round 3 years after it was founded.
4B Technologies is headquartered in Suzhou, China. It is registered at Suzhou, Jiangsu, China.
4B Technologies is a funded company, having raised a total of $14M across 2 funding rounds to date.
4B Technologies was founded in 2018 in Suzhou, China, within the biotechnology sector. Focus is placed on developing pharmaceutical candidates for neurological conditions. The pipeline includes FB-1071 targeted at amyotrophic lateral sclerosis, FB-1005 for stroke recovery, FB-1001 for glaucoma treatment, FB-1003 for pain management, and FB-1004 for Alzheimers disease. Operations center on advancing these therapies through research and development stages.
4B Technologies's top competitors include Alector, Intra-Cellular Therapies and Entrada Therapeutics.
4B Technologies has 10 investors. Key investors include Fortune Capital, Bloomage, Fangyi Equity Investment Fund, ZGC Co-Innovation Fund, and Tao Capital.